Kwang‐Su Park

机构：Keimyung University · ORCID：0000-0002-1910-3937

发表论文 119 篇 · 总被引 3401 次 · h-index 29

代表论文

• Advancing targeted protein degradation for cancer therapy (2021 · Nature reviews. Cancer · 被引 646)
• Discovery of a first-in-class EZH2 selective degrader (2019 · Nature Chemical Biology · 被引 236)
• EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis (2022 · Nature Cell Biology · 被引 191)
• A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models (2021 · Science Translational Medicine · 被引 161)
• Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation (2021 · Journal of the American Chemical Society · 被引 150)
• Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets (2022 · Journal of the American Chemical Society · 被引 143)